TOKYO, May 02, 2017 -- FRONTEO Healthcare Inc. (“FRONTEO Healthcare”), a subsidiary of FRONTEO Inc. (“FRONTEO”) (NASDAQ:FTEO) (TSE:2158) that specializes in providing medical data analysis solutions using artificial intelligence, announced today that its Board of Directors approved the replacement of Naritomo Ikeue, the current Chief Executive Officer (CEO) of FRONTEO Healthcare, with Kuniko Nishikawa, effective immediately. Additionally, Director Masahiro Morimoto was named as Executive Chairman of FRONTEO Healthcare.
Changes to the Directors of FRONTEO Healthcare (*effective May 2, 2017)
| Name | New Title | Previous Title |
| Kuniko Nishikawa | Chief Executive Officer | Independent Director |
| Naritomo Ikeue | Director | Chief Executive Officer |
| Masahiro Morimoto | Executive Chairman | Director |
Kuniko Nishikawa, the new CEO of FRONTEO Healthcare, has more than fifteen years of management experience in the medical care and nursing care industries. She has served as an Independent Director of FRONTEO Healthcare since December 2016 and is strongly committed to the development and growth of FRONTEO Healthcare. Naritomo Ikeue, the previous CEO of FRONTEO Healthcare, will continue to serve the Company as a member of the Board of Directors, responsible for the business development of FRONTEO Healthcare. As Executive Chairman, Masahiro Morimoto will support the new CEO and promote the healthcare business from the perspective of the FRONTEO group.
Background of Kuniko Nishikawa
| April 1986 | Began working at Citibank N.A. |
| February 1996 | Began working at A.T. Kearney Japan |
| September 2000 | President and CEO, Supernurse Co. Ltd. |
| August 2010 | President and CEO, Firststar Healthcare Co. Ltd. (current) |
| June 2013 | President and CEO, Benesse MCM Corp. |
| June 2015 | Independent Director, OMRON Corporation (current) |
| December 2016 | Independent Director, FRONTEO Healthcare Inc. (current) |
About FRONTEO, Inc.
FRONTEO, Inc. (“FRONTEO”) (Nasdaq:FTEO) (TSE:2158) supports the analysis of big data based on behavior informatics by utilizing its technology, "KIBIT". FRONTEO's KIBIT technology is driven by FRONTEO artificial intelligence based on knowledge acquired through its litigation support services. KIBIT incorporates experts' tacit knowledge, including their experiences and intuitions, and utilizes that knowledge for big data analysis. FRONTEO continues to expand its business operations by applying KIBIT to new fields such as healthcare and marketing. FRONTEO was founded in 2003 as a provider of e-discovery and international litigation support services. These services include the preservation, investigation and analysis of evidence materials contained in electronic data, and computer forensic investigation. FRONTEO provides e-discovery and litigation support by making full use of its data analysis platform, "Lit i View", and its Predictive Coding technology adapted to Asian languages. The company name was changed from UBIC, Inc. to FRONTEO, Inc. as of July 1, 2016.
For more information about FRONTEO, contact [email protected] or visit http://www.fronteo.com/global/.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the amount of data that FRONTEO expects to manage this year and the potential uses for FRONTEO's new service in intellectual property-related litigation, contain forward-looking statements. FRONTEO may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about FRONTEO's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: FRONTEO's goals and strategies; FRONTEO's expansion plans; the expected growth of the data center services market; expectations regarding demand for, and market acceptance of, FRONTEO's services; FRONTEO's expectations regarding keeping and strengthening its relationships with customers; FRONTEO's plans to invest in research and development to enhance its solution and service offerings; and general economic and business conditions in the regions where FRONTEO provides solutions and services. Further information regarding these and other risks is included in FRONTEO's reports filed with, or furnished to the Securities and Exchange Commission. FRONTEO does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of this press release, and FRONTEO undertakes no duty to update such information, except as required under applicable law.
CONTACT: FRONTEO Global PR [email protected]


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Washington Post Publisher Will Lewis Steps Down After Layoffs
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



